According to previous studies, TOX3 can promote the oncogenesis and development of breast cancer, colorectal cancer, and lung cancer through the MAPK, EMT, and Hippo‐related signaling pathways.12, 13. This evidence concerns the gene TOX3 and colorectal cancer.